PATHOGENETIC SUBSTANTIATION OF THE APPLICATION OF THE I-PRF TECHNIQUE IN THE TREATMENT OF GENERALIZED PERIODONTITIS ACCORDING TO THE RESEARCH DATA OF THE SCIENTIFIC LITERATURE

Authors

  • A.V. Sergeieva Institute of Postgraduate Education of the Bogomolets National Medical University

DOI:

https://doi.org/10.35220/2078-8916-2024-53-3.10

Keywords:

traumatic periodontitis, platelet factors, PRF, i-PRF, VEGF, local immunity.

Abstract

The purpose of the study. To conduct an analysis of modern literary data on the necessity and expediency of the PRF technique for the treatment of generalized traumatic periodontitis of a chronic course. The study of supra (hyper) contacts and the presence of traumatic occlusion can support the initiation of chronic inflammation in the marginal periodontium against the background of a violation of the barrier function of epithelial attachment and a widespread violation of microcirculation. Local antibacterial treatment, professional hygiene of the oral cavity only temporarily relieves the symptoms of inflammation. In this regard, research is needed to determine the capabilities of autoimmune competent cells that have immunocorrelative abilities to support the local immune status in the periodontium. This is a brief review of the literature on the use of immunocompetent cells – platelets as key regulators of inflammation and immunoregulatory factors within vascular homeostasis to support local immune status. An up-to-date pathophysiological assessment of the use of PRF and i-PRF techniques, platelet growth factors for the creation of type I collagen, which plays a leading role in repair, is given. A current pathophysiological assessment of the stagnation of PRF and i-PRF techniques, platelet growth factors for the creation of type I collagen, which plays a leading role in repair, is given. It is appreciated that macrophages in the midst of inflammation play a special role in vibrating growth factors, such as plateletderived growth factor (PDGF), transforming endothelial growth factor (TGF), which also mediates chemotaxis to stimulate angiogenesis. It was found that i-PRF can sense the functional differentiation of cells similar to osteoblasts, lower blood cells. The i-PRF culture infuses the production of primary human osteoblasts before proliferation, differentiation, mineralization of adhesion teams and migration. When administered regularly, PRF and i-PRF induce a three-fold increase in human osteoblasts and proliferation processes. A negative impact on cell vitality, metabolic activity and cell migration is prevented if the i-PRF concentration exceeds 60%. These studies concern a clinically significant topic related to the treatment of chronic periodontitis and obtained by non-surgical methods of regenerative processes in the periodontal complex, which is important for the clinical practice of dentists.

References

Akbari S., Haghani M., Ghobadi M., Hooshmandi E., Haghighi A.B., Salehi M.S., et al. Combination Therapy with Platelet-Rich Plasma and Epidermal Neural Crest Stem Cells Increases Treatment Efficacy in Vascular Dementia. Stem Cells Int. 2023. № 2023. Р. 3784843. doi: 10.1155/2023/3784843.

Anitua E., Prado R., Orive G. Allogeneic Platelet- Rich Plasma: At the Dawn of an Off-the-Shelf Therapy? Trends Biotechnol. 2017. № 35(2). Р. 91-93. doi: 10.1016/j. tibtech.2016.11.001.

Baba K., Yamazaki Y., Sone Y., Sugimoto Y., Moriyama K., Sugimoto T., Kumazawa K., Shimakura Y., Takeda A. An in vitro long-term study of cryopreserved umbilical cord blood-derived platelet-rich plasma containing growth factors-PDGF-BB, TGF-β, and VEGF. J Craniomaxillofac Surg. 2019. № 47(4). Р. 668-675.

Bellagambi F.G., Baraket A., Longo A., Vatteroni M., Zine N., Bausells J. et al. Electrochemical biosensor platform for TNF-α cytokines detection in both artificial and human saliva: heart failure. Sens Actuators B. 2017. № 251. Р. 1026–1033.

Carvalho A., Ferreira A.F., Soares M., et al. Optimization of Platelet-Rich Plasma Preparation for Regenerative Medicine: Comparison of Different Anticoagulants and Resuspension Media. Bioengineering (Basel, Switzerland). 2024. № 11(3). Р. 209.

Cengiz I.F., Oliveira J.M., Reis R.L. PRP Therapy. Adv Exp Med Biol. 2018. № 1059. Р. 241-253. doi: 10.1007/978-3-319-76735-2_11.

Chen C., Lei J., Yi X., Hua Y., Yang J. Investigation of the effect of anticoagulants on platelet recovery, enrichment factor, PDGF, TGF-β1 and optimal dose in the preparation of platelet-rich plasma. Panminerva Med. 2024. doi: 10.23736/S0031-0808.24.05169-3.

Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. International Journal of Molecular Sciences. 2020. № 21(20). Р. E7794. doi: 10.3390/ijms21207794.

Fang J., Wang X., Jiang W., et al. Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries. Tissue engineering. Part B, Reviews. 2020. № 26(6). Р. 571-585. doi: 10.1089/ten. teb.2019.0292.

Lektemur Alpan A., Torumtay Cin G., Kızıldağ A., et al. Evaluation of the effect of injectable platelet-rich fibrin (i-PRF) in wound healing and growth factor release in rats: a split-mouth study. Growth Factors (Chur, Switzerland). 2024. № 42(1). Р. 36-48.

Liao X., Liang J.X., Li S.H., Huang S., Yan J.X., Xiao L.L., Song J.X., Liu H.W. Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds. J Surg Res. 2020. № 246. Р. 284-291.

Llorián-Salvador M., González-Rodríguez S. Painful Understanding of VEGF. Front Pharmacol. 2018.№ 9. Р. 1267. doi: 10.3389/fphar.2018.01267.

Passanezi E., Campos A.P.S. Role of occlusion in periodontal disease. Periodontology 2000. 2019. № 79(1). Р. 129-150.

Vladulescu D., Scurtu L.G., Simionescu A.A, et al. Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action. Biomedicines. 2023. № 12(1). Р. 7.

Wang L., Zhang R., Xiong H., Peng B. The involvement of platelet-derived growth factor-A in the course of apical periodontitis. Int Endod J. 2011. № 44(1). Р. 65-71. doi: 10.1111/j.1365-2591.2010.01798.x.

Wiszniak S, Schwarz Q. Exploring the intracrine functions of VEGF-A. Biomolecules. 2021;11.1:128.

Мельничук Ю.М. Тромбоцитарний фактор росту, як діагностично важливий маркер фізіологічних процесів в організмі людини. Вісник проблем біології і медицини. 2014. № 3. С. 217-221.

Сулим Ю.В, Петришин О.А. Перспективи та досягнення регенерації пародонта. In: Modern and global methods of the development of scientific thought. Proceedings of the V International Scientific and Practical Conference. Florence, Italy. 2022. Р. 318-321

Сулік Я.О. Плазмотерапія (P-PRP-терапія): сучасний підхід до лікування атрофічних рубців постакне. Український журнал дерматології, венерології, косметології. 2017. № 2. Р. 84-88.

Published

2024-11-25

How to Cite

Сергєєва, А. (2024). PATHOGENETIC SUBSTANTIATION OF THE APPLICATION OF THE I-PRF TECHNIQUE IN THE TREATMENT OF GENERALIZED PERIODONTITIS ACCORDING TO THE RESEARCH DATA OF THE SCIENTIFIC LITERATURE. Stomatological Bulletin, 128(3), 56–60. https://doi.org/10.35220/2078-8916-2024-53-3.10

Issue

Section

ТЕРАПЕВТИЧНА СТОМАТОЛОГІЯ